Scholarlink

Background <p>Posttraumatic stress disorder (PTSD) is increasingly recognized as a sequela of subarachnoid hemorrhage (SAH); however, its prevalence and clinical correlates remain understudied. This study assessed the prevalence of PTSD symptoms and associated psychological symptoms among survivors of SAH.</p> Methods <p>A 6-month prospective analysis of 45 SAH survivors from the GASH trial (NCT03569540) was conducted. PTSD symptoms were evaluated using the Screen for Posttraumatic Stress Symptoms (SPTSS), with concurrent assessment of anxiety/depression (Hospital Anxiety and Depression Scale, HADS) and functional outcomes (modified Rankin Scale).</p> Results <p>At six months post-SAH, 55,56% (<i>n</i> = 25) of patients met the SPTSS criteria for significant PTSD symptoms. Avoidance (mean score: 23,36 ± 11,75) and hyperarousal (19,52 ± 10,22) were the most prominent symptoms. PTSD was strongly associated with concurrent anxiety (HADS-A ≥ 7; <i>p</i> &lt; 0.001) and depression (HADS-D ≥ 6; <i>p</i> &lt; 0.001).</p> Conclusion <p>Nearly half of SAH survivors screened positive for PTSD-related symptoms within six months, with avoidance behaviors predominating. The high comorbidity of anxiety and depression underscores the necessity for integrated neuropsychiatric care in SAH follow-up protocols.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

High prevalence of posttraumatic stress disorder in survivors of aneurysmal subarachnoid hemorrhage: a 6-month follow-up screening study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月7日

查看全文
  • Isabela Costola Windlin,
  • Bruno Braga Sisnando da Costa,
  • Pedro Henrique Mouty Rabello,
  • Ilan David Friedmann,
  • Yan Luca de Abreu Alves Jacinto,
  • Davi Jorge Fontoura Solla,
  • Carlos Gilberto Carlotti Jr. ,
  • Eberval Gadelha Figueiredo

摘要

Background

Posttraumatic stress disorder (PTSD) is increasingly recognized as a sequela of subarachnoid hemorrhage (SAH); however, its prevalence and clinical correlates remain understudied. This study assessed the prevalence of PTSD symptoms and associated psychological symptoms among survivors of SAH.

Methods

A 6-month prospective analysis of 45 SAH survivors from the GASH trial (NCT03569540) was conducted. PTSD symptoms were evaluated using the Screen for Posttraumatic Stress Symptoms (SPTSS), with concurrent assessment of anxiety/depression (Hospital Anxiety and Depression Scale, HADS) and functional outcomes (modified Rankin Scale).

Results

At six months post-SAH, 55,56% (n = 25) of patients met the SPTSS criteria for significant PTSD symptoms. Avoidance (mean score: 23,36 ± 11,75) and hyperarousal (19,52 ± 10,22) were the most prominent symptoms. PTSD was strongly associated with concurrent anxiety (HADS-A ≥ 7; p < 0.001) and depression (HADS-D ≥ 6; p < 0.001).

Conclusion

Nearly half of SAH survivors screened positive for PTSD-related symptoms within six months, with avoidance behaviors predominating. The high comorbidity of anxiety and depression underscores the necessity for integrated neuropsychiatric care in SAH follow-up protocols.